Cheng N - Search Results

1

CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.

Yao M, Fang W, Smart C, Hu Q, Huang S, Alvarez N, Fields P, Cheng N. Yao M, et al. Among authors: cheng n. Mol Cancer Res. 2019 Feb;17(2):604-617. doi: 10.1158/1541-7786.MCR-18-0750. Epub 2018 Nov 16. Mol Cancer Res. 2019. PMID: 30446625 Free PMC article.

2

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J. Cheng N, et al. Mol Cancer Res. 2002 Nov;1(1):2-11. Mol Cancer Res. 2002. PMID: 12496364

3

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.

Cheng N, Brantley D, Fang WB, Liu H, Fanslow W, Cerretti DP, Bussell KN, Reith A, Jackson D, Chen J. Cheng N, et al. Neoplasia. 2003 Sep-Oct;5(5):445-56. doi: 10.1016/s1476-5586(03)80047-7. Neoplasia. 2003. PMID: 14670182 Free PMC article.

4

Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.

Cheng N, Chytil A, Shyr Y, Joly A, Moses HL. Cheng N, et al. Cancer Res. 2007 May 15;67(10):4869-77. doi: 10.1158/0008-5472.CAN-06-3381. Epub 2007 May 10. Cancer Res. 2007. PMID: 17495323

5

Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.

Cheng N, Chytil A, Shyr Y, Joly A, Moses HL. Cheng N, et al. Mol Cancer Res. 2008 Oct;6(10):1521-33. doi: 10.1158/1541-7786.MCR-07-2203. Mol Cancer Res. 2008. PMID: 18922968 Free PMC article.

6

Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.

Hembruff SL, Jokar I, Yang L, Cheng N. Hembruff SL, et al. Among authors: cheng n. Neoplasia. 2010 May;12(5):425-33. doi: 10.1593/neo.10200. Neoplasia. 2010. PMID: 20454514 Free PMC article.

7

Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.

Fang WB, Jokar I, Chytil A, Moses HL, Abel T, Cheng N. Fang WB, et al. Among authors: cheng n. Clin Exp Metastasis. 2011 Apr;28(4):351-66. doi: 10.1007/s10585-011-9373-0. Epub 2011 Mar 4. Clin Exp Metastasis. 2011. PMID: 21374085 Free PMC article.

8

CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.

Fang WB, Jokar I, Zou A, Lambert D, Dendukuri P, Cheng N. Fang WB, et al. Among authors: cheng n. J Biol Chem. 2012 Oct 19;287(43):36593-608. doi: 10.1074/jbc.M112.365999. Epub 2012 Aug 27. J Biol Chem. 2012. PMID: 22927430 Free PMC article.

9

Priming cancer cells for drug resistance: role of the fibroblast niche.

Fang WB, Yao M, Cheng N. Fang WB, et al. Among authors: cheng n. Front Biol (Beijing). 2014 Feb 1;9(2):114-126. doi: 10.1007/s11515-014-1300-8. Front Biol (Beijing). 2014. PMID: 25045348 Free PMC article.

10

Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.

Zou A, Lambert D, Yeh H, Yasukawa K, Behbod F, Fan F, Cheng N. Zou A, et al. Among authors: cheng n. BMC Cancer. 2014 Oct 24;14:781. doi: 10.1186/1471-2407-14-781. BMC Cancer. 2014. PMID: 25344051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,257 results

Search Page

Filters